Specialty Pharmacy

Most MS patients have not considered changing their diet as a therapeutic approach.

Patient Action Plan can improve treatment across a variety of disease states in specialty pharmacy.

Catch up with the latest developments across the health care landscape and sign up for key upcoming conferences.

Research compares different methods to control the symptoms of MS.

A summary of the clinical potential of biosimilar therapies and special considerations for older patients with cancer.

Analysts believe T-cell therapies must first show curative properties in blood cancer treatment to justify the cost.

Most read articles of the week on Specialty Pharmacy Times.

Discovery holds promise for treatment of cirrhosis and liver damage related to hepatitis C.

HIV protein can impair neurocognitive function in nearly half of HIV-positive patients.

Pharmacists should engage patients in interactive conversations in order to ensure they take medications as directed.

Phase 2 trial shows reduction in the cumulative total number of gadolinium-enhancing lesions in MS patients.

Diabetes and other conditions are also influenced by a person’s height.

Antiretroviral therapy taken early and frequently can limit the spread of HIV.

Ocrevus targets a key contributor to myelin and axonal damage in primary progressive multiple sclerosis without harming other immune functions.

Gilotrif shows significant reduction in the risk of adenocarcinoma progression.

Under expanded agreements, pharmacists can establish agreements with multiple physicians in order to manage drug therapy for multiple patients.

Inherited genetic variations leave acute lymphoblastic leukemia patients sensitive to drugs and at risk for toxicity.

Researchers apply a dynamic model to analyze demand response to non-linear drug benefits using data from Medicare Part D.

New option approved for liver transplant patients and individuals with decompensated cirrhosis.

Scarring on the brain from MS can impact the ability to identify certain flavors.

Electronic prescribing systems can influence prescriber behavior and may result in lower prescription medication costs.

Enhanced tumor analysis can help identify individual therapeutic cancer strategies.

David D'Altorio, PharmD, senior vice president of health services at MedImpact Healthcare Systems, discusses the benefits of MedImpact's iRx program.

Psoriatic arthritis patients are more likely to develop conditions such as hypertension, diabetes, obesity, and dyslipidemia.

Large proportion of high risk young adults are unaware they are infected with HIV.

Vinegar works to suppress inflammation-inducing proteins while improving the gut’s bacterial makeup.

The annual cost to the Medicare system for IPF is estimated to be $1 billion annually.

Many consumers are spending more than necessary as a result of choosing the wrong health insurance plan.